CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Rohto Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Rohto Pharmaceutical Co Ltd
1-8-1, Tatsumi-Nishi, Ikuno-ku
Phone: +81 667581231p:+81 667581231 OSAKA-SHI, OSK  544-8666  Japan Ticker: 45274527
Business Summary
ROHTO PHARMACEUTICAL CO., LTD. is a Japan-based company principally engaged in the health and beauty care area. The Company primarily provides eye care-related products, including eye drops and eye lotions; skin care-related products, including dermatological preparations, lip balms, sunscreens and functional cosmetics; oral medication and food-related products, including digestive medicines, Chinese herbal medicines and supplements, as well as extracorporeal test drugs and other products. The Company operates its business in domestic market and overseas markets, including Europe, Asia and America.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20243/31/2024Yes---Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations
2844 Perfumes, cosmetics, and other toilet preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer, Chairman of Subsidiary, Representative Director KunioYamada 68 6/1/2019 6/1/1991
President, Chief Operating Officer, Chairman of Subsidiary, Representative Director MasashiSugimoto 61 8/1/2021 6/1/2019
Vice President, Chief Financial Officer, Chairman and President of Subsidiaries, Director MasayaSaito 59 3/1/2022 6/23/2011
10 additional Officers and Directors records available in full report.

Business Names
Business Name
4527
Agera Laboratories Inc.
AJ North (Proprietary) Limited
4 additional Business Names available in full report.

General Information
Number of Employees: 7,259 (As of 3/31/2024)
Outstanding Shares: 228,138,738 (As of 9/30/2024)
Shareholders: 32,079
Stock Exchange: TYO
Federal Tax Id: 000009461


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024